Blood

Vol. 147, Issue 1 Issue 1 2026
15
Articles

Articles in this Issue

New insights into trauma: TG2 and fibrin cross-linking

Zhouzhou Yao, Yang Xia Jan 01, 2026 pp. 10-12 10.1182/blood.2025031254

Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma

Zhibo Yan, Zhannan Han, Yihui Wang et al. Jan 01, 2026 pp. 48-60 10.1182/blood.2025029950

Abstract The progression of multiple myeloma (MM), an incurable malignancy of plasma cells, is often associated with the suppression of ferroptosis, a type of cell death driven by...

STK10 emerges from the platelet kinome shadow

K. Vinod Vijayan Jan 01, 2026 pp. 8-10 10.1182/blood.2025031613

How blasts get into the skin—and how to get rid of them

Christoph Schmid Jan 01, 2026 pp. 4-5 10.1182/blood.2025031448

Fetal defense against leukemia: a developmental shield

Karen Keeshan Jan 01, 2026 pp. 7-8 10.1182/blood.2025031544

Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia

Jennifer R. Brown, Bastien Nguyen, Sai Prasad Desikan et al. Jan 01, 2026 pp. 24-34 10.1182/blood.2024027009

Abstract Pirtobrutinib, a noncovalent, reversible Bruton tyrosine kinase inhibitor (BTKi), demonstrated efficacy in patients with chronic lymphocytic leukemia (CLL), resistant to c...

<i>Blood</i> : flowing stronger than ever after 80 years

Andrew W. Roberts Jan 01, 2026 pp. 1-1 10.1182/blood.2025032375

Mechanisms of immune escape and extramedullary tropism in leukemia cutis

Livius Penter, Katie Maurer, Nicoletta Cieri et al. Jan 01, 2026 pp. 35-47 10.1182/blood.2025029121

Abstract The mechanisms that lead to extramedullary tropism of acute myeloid leukemia (eAML) remain obscure and no specific therapeutic approaches for this entity exist. Because th...

Fetal context conveys heritable protection against MLL-rearranged AML that depends on MLL3

Jonny Mendoza-Castrejon, Wei Yang, Elisabeth Denby et al. Jan 01, 2026 pp. 61-72 10.1182/blood.2025029686

Abstract MLL rearrangements (MLLrs) are the most common cause of congenital and infant leukemias. MLLrs arise prior to birth and can transform fetal/neonatal progenitors with the h...

Targeting STK17B: unlocking ferroptosis in myeloma

Bei Liu Jan 01, 2026 pp. 6-7 10.1182/blood.2025031316

Measurable residual disease intervention in AML: a new therapeutic horizon

Andrew H. Wei, Harry J. Iland, Courtney D. DiNardo et al. Jan 01, 2026 pp. 13-23 10.1182/blood.2025029010

Abstract Acute myeloid leukemia (AML) is a polyclonal malignancy marked by high relapse rates despite initial morphologic remission. Although measurable residual disease (MRD) is a...

Tissue transglutaminase drives fibrin β-chain cross-linking: a novel fibrin modification observed in patients with trauma

Nana Kwame Kwabi Boateng, Riley Wimberley, Jacob Rose et al. Jan 01, 2026 pp. 87-92 10.1182/blood.2025029458

Abstract Covalent cross-linking of fibrin by the plasma transglutaminase coagulation factor XIII (FXIII) is a key determinant of blood clot stability and function. FXIII-catalyzed...

Pal R, Janz M, Galson DL, et al. C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells. <i>Blood</i> . 2009;114(18):3890-3898.

Jan 01, 2026 pp. 93-94 10.1182/blood.2025031856

Shifting clones: CLL evolution under pirtobrutinib treatment

Billy Michael Chelliah Jebaraj, Stephan Stilgenbauer Jan 01, 2026 pp. 3-4 10.1182/blood.2025031598

STK10 regulates platelet function in arterial thrombosis and thromboinflammation

Yingying Li, Hui Zhu, Yun Liu et al. Jan 01, 2026 pp. 73-86 10.1182/blood.2025030134

Abstract Serine/threonine kinase 10 (STK10) is a member of the Ste20 family of serine/threonine kinases and regulates lymphocyte adhesion. Quantitative phosphoproteomic assay showe...

All Issues

Journal Info

Publisher Elsevier BV
ISSN 0006-4971
E-ISSN 1528-0020
Subject Health Sciences
Language English
View Full Journal Page